BiomeAide-SR
Withdrawn from the US market on 27 February 2024 (according to the DSLD)
Tesseract Medical Research, food supplement from the US market
Label withdrawn from the US market. BiomeAide-SR (Tesseract Medical Research), a food supplement without a usable barcode in DSLD, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Tesseract Medical Research
- Barcode
- Not provided or invalid in DSLD
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- CyLoc, Hydroxypropyl Methylcellulose, Hypromellose, Calcium Laurate, Amylase, Plant
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| BiomeAide Complex | Blend | 275 mg |
| BiomeAide | Blend | not stated |
| Ginger | Plant | not stated |
| Cinnamomum | Plant | not stated |
| Citronella | Plant | not stated |
| Orange (Citrus sinensis) | Plant | not stated |
| Lavender (Lavandula angustifolia) | Plant | not stated |
| Bitter Orange (Citrus aurantium) | Plant | not stated |
| Clove (Syzygium aromaticum) | Plant | not stated |
| Oregano | Plant | not stated |
| Thyme Oil (Thymus vulgaris) | Plant | not stated |
| Marjoram Oil (Origanum majorana) | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: BiomeAide-SR
Entered into DSLD on 22 January 2022. Withdrawn from the US market on 22 February 2023 (according to the DSLD).- Same quantity, different name: BiomeAide Complex Io in this version; BiomeAide Complex on the displayed label (275 mg)
- Same quantity, different name: Thyme in this version; Thyme Oil on the displayed label (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thyme Oil
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Tesseract Medical Research
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.